25.14USD+1.29%Mkt Cap: 143.28B $P/E: 19.191d ago
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The co…
Industry Peers
Drug Manufacturers - General$1.04TUSDP/E 41.6
$601.73BUSDP/E 29.0
$449.42BUSDP/E 124.1
$305.83BUSDP/E 21.0
$315.22BUSDP/E 36.0
$272.16BUSDP/E 21.8
$268.42BUSDP/E 21.8
$243.51BUSDP/E 25.4
$216.37BUSDP/E 12.3
$212.87BUSDP/E 25.1
$200.54BUSDP/E 25.9
$169.23BUSDP/E 18.5
$123.57BUSDP/E 16.9
$100.10BUSDP/E 19.4
$85.16BUSDP/E 13.8
$50.96BUSD
$30.84BUSDP/E 22.4
MRV
Marvell Technology, Inc.$20.08BUSDP/E 7.4
$11.37BUSDP/E 22.7
$10.53BUSDP/E 18.3
$10.47BUSDP/E 18.2
$6.76BUSDP/E 15.0
$3.54BUSDP/E 14.5
$2.97BUSDP/E 18.1
$61.82MUSD
$39.24MUSD
ELXR
Elixxer Ltd.$9.51MUSD
FR0000140022
SANOFITP29OCT49—
CELG-RI
Bristol-Myers Squibb Company Ce—
FLXN
Horizon Flexible Income ETF—P/E 27.0
ROSE
DocMorris AG—
Indicators:|
Key Statistics
Company
Market Cap143.28B $
Enterprise Value195.24B $
Revenue (TTM)63.32B $
Gross Profit46.51B $
Net Income (TTM)7.77B $
Revenue/Share11.13 USD
Last Price25.14 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees75.0K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - General
ISINUS7170811035
Valuation
P/E (Trailing)19.19
P/E (Forward)8.87
PEG2.83
EV/EBITDA7.67
EV/Revenue3.08
P/S2.26
P/B1.59
EPS (TTM)1.31
EPS (Forward)2.83
52W Range
23.1136% of range28.75
52W High28.75 USD
52W Low23.11 USD
Profitability
Gross Margin74.33%
Oper. Margin31.62%
EBITDA Margin40.21%
Profit Margin12.42%
ROE8.99%
ROA3.73%
Growth
Revenue Growth5.40%
Earnings Growth-10.10%
Cash Flow & Leverage
Operating CF11.70B $
CapEx (TTM)2.63B $
FCF Margin19.55%
FCF Yield8.64%
Net Debt51.65B $
Net Debt/EBITDA2.03
Balance Sheet
Debt/Equity0.74
Current Ratio1.25
Quick Ratio0.85
Book Value/Sh15.81 USD
Cash/Share2.295 USD
Dividends
Fwd Div Rate1.720 USD
Trail. Div Rate1.720 USD
Div. Yield6.93%
5Y Avg Yield5.10%
Payout Ratio131.30%
Ex-Div DateJul 24, 2026
Pay DateSep 1, 2026
Splits
Last Split1054:1000
Split DateNov 17, 2020
Analyst Consensus
Rating2.5 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)28.79 USD
Upside (mean)+14.5%
Target Range24.00 USD – 35.46 USD
$24.00+14.5% to mean$35.46
# Analysts26
Ownership
Shares Out.5.70B
Float5.69B
Insiders0.10%
Institutions69.52%
Short Interest
Short Ratio3.5d
Short % Float2.87%
Short % Out.2.87%
Shares Short163.58M
Short (prev mo.)162.66M
Technical
SMA 5025.30 (-0.6%)
SMA 20025.88 (-2.9%)
Beta0.31
S&P 52W Chg19.63%
Avg Vol (30d)40.82M
Avg Vol (10d)42.86M
Technical Indicators
RSI (14)54.9
MACD-0.2352
MACD Signal-0.3838
MACD Hist.+0.1485
BB Upper25.56 USD
BB Middle24.43 USD
BB Lower23.29 USD
BB Width9.28%
ATR (14)0.5319 USD
Vol Ratio (20d)0.96x